India's hospitals are treating the world: how medical tourism became a $12 billion industry

India received approximately 700,000 international medical tourists in FY 2025-26, generating revenues of around $12 billion — up from $9 billion in FY23. The top source countries are Bangladesh (the largest by volume), Afghanistan, Iraq, Maldives, Kenya, and Nigeria. The attraction is a combination of clinical quality and price: a cardiac bypass surgery in Delhi costs $5,000-10,000 against $70,000-100,000 in the United States, while quality at India's top hospitals meets or exceeds regional alternatives. The government has backed this with the Heal in India initiative, e-Medical Visa fast-tracks, and dedicated patient facilitation desks at airports. India now ranks second globally in medical tourism competitiveness (after Thailand, per the Medical Tourism Index 2025), and the sector is projected to reach $20 billion by 2030.

India's medical tourism advantage rests on three pillars built over three decades. The first is private hospital investment: Apollo Hospitals (founded 1983), Fortis, Manipal, and Narayana Health have collectively invested billions in world-class infrastructure — JCI-accredited operating theatres, internationally trained surgeons, and ISO-certified processes. The second is medical education scale: India graduates 50,000 MBBS doctors and 25,000 specialists per year — the largest medical graduate pool in the world — keeping specialist salaries 5-10× below Western equivalents. The third is English fluency and cultural familiarity: India's colonial history produced an English-speaking medical establishment that makes communication easy for patients from Africa, the Middle East, and Southeast Asia. Visa simplification (the e-Medical Visa) and government promotion through Heal in India turned a latent advantage into a marketable product.

Approximate costs at top Indian hospitals vs US: cardiac bypass (India $6,000 / US $80,000), knee replacement (India $7,500 / US $40,000), liver transplant (India $35,000 / US $300,000), IVF cycle (India $3,500 / US $20,000). Top procedure categories: cardiac (28%), orthopaedic (19%), oncology (15%), fertility (12%), ophthalmology (10%). Top source countries by volume: Bangladesh, Afghanistan, Iraq, Maldives, Nigeria. JCI-accredited hospitals in India: 75+, the most in Asia after Thailand. Heal in India e-Medical Visa approval: under 72 hours. Annual foreign patient count: 700,000+ in FY26. Revenue mix: roughly 70% from surgical procedures, 20% from diagnostics and follow-up, 10% from wellness and AYUSH packages. The sector employs an estimated 4-5 lakh people directly across hospital, hospitality, and patient-coordination roles.

Myth: Indian hospitals are cheap because quality is low. Fact: JCI accreditation — the global gold standard for hospital safety and quality — is held by 75+ Indian hospitals, more than any other Asian nation except Thailand. Multiple peer-reviewed studies published in the Lancet and BMJ have documented outcomes at Apollo and Narayana Health equal to or better than UK NHS outcomes for comparable procedures. Myth: Only poor patients choose India. Fact: A growing proportion of medical tourists are middle-class patients from UK, Canada, and Australia who face long wait times at home (the average NHS wait for a hip replacement is 18 months; Apollo delivers it in 3 days). Myth: Medical tourism benefits only the private sector. Fact: AIIMS New Delhi treats over 50,000 international patients per year, mostly from South Asian neighbours, at near-public rates. Government hospitals capture a significant fraction of lower-income medical tourists, effectively providing subsidised care to neighbouring-country nationals.

For a Bangladeshi dialysis patient, a Nigerian cancer patient, or an Iraqi cardiac case, India represents the difference between receiving specialist treatment and not receiving it at all — their home healthcare systems either lack the facilities or the waiting lists are months-long. For Indian hospitals, international patients pay in foreign exchange (dollar/euro/dirham), carry higher margins than domestic patients, and subsidise the cross-subsidy model that keeps charity wards running. For Indian doctors and nurses, international exposure improves clinical skills and career opportunities. The tensions: international patients can displace domestic ones for scarce ICU beds; and the profit motive can push overtreatment. NABH and JCI accreditation aim to police both, but enforcement is uneven. The migrant medical-tourism economy around big hospital clusters — translators, hotels, food, transport — gives jobs to thousands of lower-skilled workers in Chennai, Bengaluru, and south Delhi.

India's medical tourism target of $20 billion by 2030 implies 7-10% compound growth — achievable but requiring two things: more capacity and better air connectivity. The post-COVID rebound in medical tourism has strained bed availability at top hospitals; Apollo and Fortis are expanding. Air connectivity is improving — direct Kolkata-Dhaka, Mumbai-Lagos, and Delhi-Nairobi routes have reduced the travel barrier. India's AYUSH medicine (Ayurveda, Yoga, Unani, Siddha, Homeopathy) is an additional draw: wellness tourism and post-operative Ayurveda packages are growing faster than surgical volumes. The long-term threat to India's position is Thailand, Malaysia, and Turkey — all investing heavily in medical infrastructure to capture the same global patient flow. India's answer must be deeper specialisation (complex cancer surgeries, rare-disease diagnosis, gene therapy) that lower-cost competitors cannot quickly replicate. The long-term consequence: India can either lock in a structural healthcare-export edge or lose it to faster-moving rivals.

India's hospitals are treating the world: how medical tourism became a $12 billion industry

Understand in 2 minutes

Why India became the world's hospital

Medical tourism by the numbers

More in Health

India's childhood obesity crisis: 12 million children now obese, schools feeding the problem

India's blood donation crisis: 4 million units short and getting worse

India has 400 sports medicine specialists for 1.4 billion people

Indian pharma is breaking into Big Pharma's biologics market

India's hidden hunger hits all income levels: B12, iron, vitamin D

127 essential medicines are missing from India's government hospitals

Three myths about Indian medical tourism

What it means for patients and providers

The road to $20 billion by 2030

India's medical tourism rise

Apollo Hospitals founded in Chennai

India enters global medical tourism radar

Heal in India initiative launched

Post-COVID medical tourism surge — backlog from lockdowns

India declared world's #2 medical tourism destination